LFG
MDT icon

Lazard Frères Gestion’s Medtronic MDT Stock Holding History

Lazard Frères Gestion’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Sell
1,570,835
-10,020
-0.6% -$808K 2.13% 14
2026
Q1 		$137M Sell
1,580,855
-125,081
-7% -$12M 2.7% 10
2025
Q4 		$164M Buy
1,705,936
+175,159
+11% +$17M 2.95% 10
2025
Q3 		$146M Buy
1,530,777
+91,505
+6% +$8.41M 2.78% 10
2025
Q2 		$125M Buy
1,439,272
+58,142
+4% +$4.93M 2.62% 10
2025
Q1 		$124M Sell
1,381,130
-149,803
-10% -$13.4M 3.02% 11
2024
Q4 		$122M Buy
1,530,933
+371,742
+32% +$32.2M 2.45% 14
2024
Q3 		$104M Buy
1,159,191
+220,556
+23% +$18.6M 2.21% 16
2024
Q2 		$71.5M Buy
938,635
+107,475
+13% +$8.81M 1.65% 21
2024
Q1 		$69.5M Buy
831,160
+65,431
+9% +$5.58M 1.72% 20
2023
Q4 		$60.1M Buy
765,729
+59,266
+8% +$4.52M 1.73% 19
2023
Q3 		$53.6M Buy
706,463
+5,974
+0.9% +$500K 1.7% 21
2023
Q2 		$58.8M Buy
700,489
+22,187
+3% +$1.91M 1.8% 17
2023
Q1 		$48.7M Buy
678,302
+57,935
+9% +$4.72M 1.8% 18
2022
Q4 		$46.5M Buy
620,367
+40,330
+7% +$3.27M 1.68% 21
2022
Q3 		$47.5M Buy
580,037
+7,066
+1% +$635K 1.8% 18
2022
Q2 		$50M Buy
572,971
+2,643
+0.5% +$268K 1.8% 17
2022
Q1 		$59.2M Buy
570,328
+38,211
+7% +$4.04M 1.78% 18
2021
Q4 		$50.9M Buy
532,117
+10,182
+2% +$1.18M 1.37% 25
2021
Q3 		$65.4M Buy
521,935
+460
+0.1% +$59.5K 1.84% 21
2021
Q2 		$54.6M Sell
521,475
-16,635
-3% -$2.09M 1.76% 23
2021
Q1 		$54.1M Buy
538,110
+5,510
+1% +$646K 1.88% 23
2020
Q4 		$62.6M Buy
+532,600
New +$58.6M 2% 25

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Lazard Frères Gestion's MDT Position: Q2 2026 in Review

Lazard Frères Gestion reduced its Medtronic (MDT) stake by 0.63% in Q2 2026, selling an estimated $808K and leaving 1,570,835 shares worth $123M. The position accounts for 2.13% of the portfolio, ranked #14.

Lazard Frères Gestion first reported a position in MDT in Q4 2020 and has held it in 23 quarters since. The position peaked at $164M in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lazard Frères Gestion held 1,570,835 shares of Medtronic worth $123M as of Q2 2026.
  • Lazard Frères Gestion sold 10,020 Medtronic shares in Q2 2026, an estimated $808K.
  • Medtronic made up 2.13% of Lazard Frères Gestion's portfolio in Q2 2026, its #14 holding.
  • Lazard Frères Gestion first reported a position in Medtronic in Q4 2020 and has held it in 23 quarters since.
  • Lazard Frères Gestion's Medtronic position peaked at $164M in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lazard Frères Gestion's 13F filing for Q2 2026, filed 6 Aug 2026.